TGFB1 containing EVs has been reported to bind to the receptors present on the recipient cells and activating SMAD dependent or SMAD independent signaling regulating the expression of oncogenes (PI3K, AKT, N-cadherin, vitronectin, MMPs) (30) and promoting tumor cell proliferation, invasion. The gene discussed is CDH2; the disease is neoplasm.